Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke-Reference-Cited by-同舟云学术

Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke

Published:2007-06 Issue:4 Volume:18 Page:365-370
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Rooth Elisabeth,Wallen Hakan,Antovic Alexandra,von Arbin Magnus,Kaponides Georgios,Wahlgren Nils,Blombäck Margareta,Antovic Joven

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference34 articles.

1. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view;Folsom;Thromb Haemost,2001

2. Stroke. A practical guide to management;Warlow,1996

3. Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome;Feinberg;Stroke,1996

4. Alterations of haemostatic markers in various subtypes and phases of stroke;Yamazaki;Blood Coagul Fibrinolysis,1993

5. Hemostatic risk factors for cardiovascular disease;Cushman;Hematology,1999

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients;Frontiers in Neurology;2021-02-22

2. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?;International Journal of Molecular Sciences;2021-01-17

3. Diagnostic Accuracy in Acute Venous Thromboembolism: Comparing D-Dimer, Thrombin Generation, Overall Hemostatic Potential, and Fibrin Monomers;TH Open;2020-07

4. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding;JCI Insight;2019-10-03

5. Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction;Journal of Thrombosis and Haemostasis;2017-12-26